Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 7, 2012, Pages 911-914

  Gulliver, W P ^a,b   Jemec, G B E ^c   Baker, K A ^b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b NewLab Life Sciences   (Canada)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; CLINDAMYCIN; EFALIZUMAB; INFLIXIMAB; ISOTRETINOIN; RESORCINOL; RETINOID; RIFAMPICIN; STEROID; TETRACYCLINE; TRIAMCINOLONE; USTEKINUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ARTHRITIS; ARTICLE; CASE REPORT; CLINICAL EFFECTIVENESS; CYSTITIS; DERMATITIS; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HUMAN; MALE; PHYSICIAN GLOBAL ASSESSMENT; PRIORITY JOURNAL; PSORIASIS; RATING SCALE; REMISSION; STAPHYLOCOCCUS INFECTION; SUPPURATIVE HIDRADENITIS; THERAPY EFFECT; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84862755439     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04123.x     Document Type: Article

References (21)

1. Kurzen H, Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa? Exp Dermatol 2008; 17: 455-456; discussion 457-472.
2. Alikhan A, Lynch PJ, Eisen DB,. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60: 539-561. quiz 562-533.
3. Sartorius K, Emtestam L, Jemec GB, Lapins J,. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 2009; 161: 831-839.
4. von der Werth JM, Jemec GB,. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001; 144: 809-813. (Pubitemid 32374785)
5. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J,. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007; 56: 621-623. (Pubitemid 46400178)
6. von der Werth JM, Williams HC,. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2000; 14: 389-392. (Pubitemid 32898893)
7. Haslund P, Lee RA, Jemec GB,. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venereol 2009; 89: 595-600.
8. Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA,. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol 2010; 62: 205-217.
9. Adams DR, Yankura JA, Fogelberg AC, Anderson BE,. Treatment of hidradenitis suppurativa with etanercept injection. Arch Dermatol 2010; 146: 501-504.
10. Fardet L, Dupuy A, Kerob D, et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol 2007; 56: 624-628. (Pubitemid 46400174)
11. Moschella SL,. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases. Int J Dermatol 2007; 46: 1287-1291.
12. Usmani N, Clayton TH, Everett S, Goodfield MD,. Variable response of hidradenitis suppurativa to infliximab in four patients. Clin Exp Dermatol 2007; 32: 204-205. (Pubitemid 46233031)
13. Goertz RS, Konturek PC, Naegel A, et al. Experiences with a long-term treatment of a massive gluteal acne inversa with infliximab in Crohn's disease. Med Sci Monit 2009; 15: CS14-18.
14. Poulin Y,. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept. J Cutan Med Surg 2009; 13: 221-225.
15. Blanco R, Martinez-Taboada VM, Villa I, et al. Long-term successful adalimumab therapy in severe hidradenitis suppurativa. Arch Dermatol 2009; 145: 580-584.
16. Toichi E, Torres G, McCormick TS, et al. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J Immunol 2006; 177: 4917-4926. (Pubitemid 44469828)
17. Jemec GB,. Hidradenitis suppurativa. J Cutan Med Surg 2003; 7: 47-56.
18. Martinez F, Nos P, Benlloch S, Ponce J,. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflamm Bowel Dis 2001; 7: 323-326.
19. Adams DR, Gordon KB, Devenyi AG, Ioffreda MD,. Severe hidradenitis suppurativa treated with infliximab infusion. Arch Dermatol 2003; 139: 1540-1542. (Pubitemid 37523071)
20. Roussomoustakaki M, Dimoulios P, Chatzicostas C, et al. Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapy. J Gastroenterol 2003; 38: 1000-1004. (Pubitemid 37455790)
21. Mekkes JR, Bos JD,. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br J Dermatol 2008; 158: 370-374.